Active, Not Recruiting
Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC) - CA209-913
Updated: 5 December, 2018 | ClinicalTrials.gov
Print Friendly Summary
Trial Details
Gender(s)
Age Range
Active, Not Recruiting
Treatment Options
Inclusion Criteria: Cohort 1 and 2: - Patients 18 years of age or older at SCLC diagnosis - Confirmed diagnosis of SCLC within the patient identification period (between October 2013 and October 2015) - Initiated on first-line treatment (radiotherapy and/or chemotherapy) for their SCLC - Full oncology medical history for the mandatory variables of the study available in the participating center from day of diagnosis until the end of follow-up or death (whichever occurs first) - Signed informed consent (where required as per local requirements) Cohort 3: - Patients 18 years of age or older at SCLC diagnosis - Confirmed diagnosis of SCLC not earlier than October 2013 - Initiated on second-line treatment due to relapse after first-line therapy not later than August 2016 - Full oncology medical history for the mandatory variables of the study available in the participating center from day of diagnosis until the end of follow-up or death (whichever occurs first) - Signed informed consent (where required as per local requirements) Exclusion Criteria: - Participants with previous malignancies (except non-melanoma skin cancers, and in situ cancers such as the following: bladder, gastric, colon, cervical/dysplasia, melanoma, or breast) are excluded unless a complete remission was achieved at least 2 years prior to first treatment and no additional therapy is required or anticipated to be required during the study period. Other Inclusion/Exclusion criteria may apply
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information